On-going prospective study to measure serum progranulin/GP88 levels in metastatic breast cancer patients in association with disease status

被引：0
|
作者：
Serrero, Ginette
Rosenblatt, Paula
Tait, Nancy
Rector, Barbara
Latteri, Jennifer A.
Yue, Binbin
Tkaczuk, Katherine
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-OT3-16-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT3-16-01
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Serum progranulin (GP88) level correlates with change in RECIST and survival in metastatic breast cancer
    Serrero, Ginette
    Hicks, David
    Hawkins, Douglas
    Yue, Binbin
    Rosenblatt, Paula
    Tait, Nancy
    Tkaczuk, Katherine
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Determination of a serum progranulin (GP88/PGRN) level associated with overall survival in metastatic breast cancer patients
    Serrero, G.
    Hawkins, D. M.
    Yue, B.
    Hicks, D.
    Tait, N.
    Tkaczuk, K. R.
    CANCER RESEARCH, 2017, 77
  • [3] Circulating progranulin (GP88/PGRN) level correlates with survival in metastatic breast cancer patients
    Serrero, Ginette
    Hicks, David
    Yue, Binbin
    Hawkins, Douglas M.
    Tait, Nancy
    Tkaczuk, Katherine H.
    CANCER RESEARCH, 2016, 76
  • [4] Determination of serum progranulin (GP88) levels complements CA15-3 to monitor disease progression & response to therapy in metastatic breast cancer patients
    Serrero, Ginette
    Tkaczuk, Katherine R.
    Hawkins, Douglas
    Tait, Nancy
    Yue, Binbin
    CANCER RESEARCH, 2021, 81 (04)
  • [5] GP88 Serum Level Is Increased in Breast Cancer Patients with Disease Progression
    Serrero, G.
    Tkaczuk, K.
    Yue, B.
    Kamimura, S.
    Tait, N.
    Zhan, M.
    Ecklund, D.
    CANCER RESEARCH, 2009, 69 (24) : 836S - 836S
  • [6] Increased levels of the circulating growth factor GP88 in the serum of breast cancer patients
    Serrero, G
    Tkaczuk, KH
    Golubeva, O
    Jones, L
    Tait, N
    Feldman, FS
    Dai, H
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S84 - S84
  • [7] Association between increased serum GP88 (progranulin) concentrations and prognosis in patients with malignant lymphomas
    Yamamoto, Yasuko
    Goto, Naoe
    Takemura, Masao
    Yamasuge, Wakana
    Yabe, Kuniaki
    Takami, Tsuyoshi
    Miyazaki, Tatsuhiko
    Takeuchi, Tamotsu
    Shiraki, Makoto
    Shimizu, Masahito
    Adachi, Seiji
    Saito, Koshiro
    Shibata, Yuhei
    Nakamura, Nobuhiko
    Hara, Takeshi
    Serrero, Ginette
    Saito, Kuniaki
    Tsurumi, Hisashi
    CLINICA CHIMICA ACTA, 2017, 473 : 139 - 146
  • [8] On-going phase 1A clinical trial of A01, a chimerized monoclonal antibody to Progranulin/Glycoprotein 88 (GP88) in patients with advanced malignancy
    Tkaczuk, Katherine
    Rosenblatt, Paula
    Mehra, Ranee
    Scilla, Katherine
    Tait, Nancy
    Yue, Binbin
    Serrero, Ginette
    CANCER RESEARCH, 2024, 84 (09)
  • [9] Increased Circulating Level of the Survival Factor GP88 (Progranulin) in the Serum of Breast Cancer Patients When Compared to Healthy Subjects
    Tkaczuk, Katherine Rak
    Yue, Binbin
    Zhan, Min
    Tait, Nancy
    Yarlagadda, Lavanya
    Dai, Huifang
    Serrero, Ginette
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2011, 5 : 155 - 162
  • [10] Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival
    Greither, Thomas
    Fischer, Kersten
    Theil, Gerit
    Marcou, Marios
    Holzhausen, Hans-Juergen
    Weigelt, Katrin
    Serrero, Ginette
    Hicks, David
    Yue, Binbin
    Fornara, Paolo
    Wullich, Bernd
    Taubert, Helge
    Wach, Sven
    Lieb, Verena
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 4173 - 4180
12345